Biological activities of ginseng and its application to human health

Herbal Medicine: Biomolecular and Clinical Aspects: Second Edition

Volumn , Issue , 2011, Pages 157-174

  Wee, Jae Joon ^a   Park, Kyeong Mee ^b   Chung, An Sik ^c  

^a KT and G Central Research Institute   (South Korea)

^b Daejeon University   (South Korea)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85059447148     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (117)

1. Ahn, B. Z., S. I. Kim, and Y. H. Lee. 1989. Acetyl panaxydol and panxydolchlorohydrin, two new polyenes from Korean ginseng with cytotoxic activity against L1210 cells. Arch Pharm 322:223-6.
2. Attele, A. S., Y. P. Zhou, J. T. Xie et al. 2002. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 51:1851-8.
3. Bae, E. A., M. J. Han, M. K. Choo, S. Y. Park, and D. H. Kim. 2002. Metabolism of 20(S)- and 20(R)-gensenoside Rg3 by human intestinal bacteria and its relation to in vivo biological activities. Biol Pharm Bull 25:58-63.
4. Chang, Y., W. J. Huang, L. T. Tien, and S. J. Wang. 2008. Ginsenosides Rg1 and Rb1 enhance glutamate release through activation of protein kinase A in rat cerebrocortical nerve terminals (synaptosomes). Eur J Pharmacol 578:28-36.
5. Chang, Y., and S. J. Wang. 2008. Ginsenosides Rg1 and Rb1 enhance glutamate exocytosis from rat cortical nerve terminals by affecting vesicle mobilization through the activation of protein kinase C. Eur J Pharmacol 590:74-9.
6. Chen, X. C., Y. Chen, Y. G. Zhu, F. Fang, and L. M. Chen. 2002. Protective effect of ginsenoside Rg1 against MPTP-induced apoptosis in mouse substantia nigra neurons. Acta Pharmacol Sin 23:829-34.
7. Chen, J., Y. S. Gong, and J. T. Zhang. 2001. Effects of 17 estradiol and total ginsenoside on the spatial learning and memory impairment of ovariectomy rats. Chin Pharm J 36:522-6.
8. Cheng, C. C., S. M. Yang, C. Y. Huang, J. C. Chen, W. H. Chang, and S. L. Hsu. 2005. Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells. Cancer Chemother Pharmacol 55:531-40.
9. Cho, W. C., W. S. Chung, S. K. Lee, A. W. Leung, C. H. Cheng, and K. K. Yue. 2006. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficiency in streptozotocin-induced diabetic rats. Eur J Pharmacol 550:173-9.
10. Choi, S., T. W. Kim, and S. V. Singh. 2009. Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15Ink4B and p27 Kip1-dependent inhibition of cyclin-dependent kinases. Pharm Res 26(10):2280-8.
11. Christensen, L. P. 2009. Ginsenosides: Chemistry, biosynthesis, analysis, and potential health effects. Adv Food Nutr Res 55:1-99.
12. Chung, S. H., and C. G. Choi. 2001. Comparisons between white ginseng radix and rootlet for antidiabetic mechanism in KKAy mice. Arch Pharm Res 24:214-8.
13. Dey, L., J. T. Xie, A. Wang, J. Wu, S. A. Maleckar, and C. S. Yuan. 2003. Anti-hyperglycemic effects of ginseng: Comparison between root and berry. Phytomedicine 10:600-5.
14. DiGiovanni, J. 1992. Multistage carcinogenesis in mouse skin. Pharmacol Ther 54:63-128.
15. Etou, H., T. Sakata, K. Fujimoto et al. 1988. Ginsenoside Rb1 as a suppressor in central modulation of feeding in the rat. Nippon Yakurigaku Zasshi 91(1):9-15.
16. Friedl, R., T. Moeslinger, B. Kopp, and P. G. Spieckermann. 2001. Stimulation of nitric oxide synthesis by the aqueous extract of Panax ginseng root in RAW 264.7 cells. Br J Pharmacol 134:1663-70.
17. Fujimoto, K., T. Sakata, T. Ishimaru et al. 1989. Attenuation of anorexia induced by heat or surgery during sustained administration of ginsenoside Rg1 into rat third ventricle. Psychopharmacology 99(2):257-60.
18. Fukushima, S., H. Wanibuchi, and W. Li. 2001. Inhibition of ginseng of colon carcinogenesis in rats. J Korean Med Sci 16(Suppl.):S75-80.
19. Gao, H., F. Wang, E. J. Lien, and M. D. Trousdale. 1996. Immunostimulating polysaccharides from Panax notoginseng. Pharm Res 13:1196-200.
20. Gillis, C. N. 1997. Panax ginseng pharmacology: A nitric oxide link? Biochem Pharmacol 54:1-8.
21. Gotteeman, M. M., and I. Pastan. 1993. Biochemistry of multidrug resistance mediated by the multidrug transport. Annu Rev Biochem 62:385-427.
22. Guo, L., L. Song, Z. Wang, W. Zhao, W. Mao, and Y. Ming. 2009. Panaxydol inhibits the proliferation and induces the differentiation of human hepatocarcinoma cell lineHepG2. Chem Biol Interact 181:138-43.
23. Han, C. G., S. K. Ko, J. H. Sung, and S. H. Chung. 2007. Compound K enhances insulin secretion with beneficial metabolic effects in db/db mice. J Agric Food Chem 55:10641-8.
24. Han, S. K., J. Y. Song, Y. S. Yun, and S. Y. Yi. 2005. Ginseng improved Th1 immune response inhibited by gamma radiation. Arch Pharm Res 28:343-50.
25. Hasegawa, H., J. H. Sung, S. Matsumiya, and M. Uchiyama. 1996. Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med 62:453-7.
26. Helms, S. 2004. Cancer prevention and therapeutics: Panax ginseng. Altern Med Rev 9:259-74.
27. Huang, K. C. 1999. The Pharmacology of Chinese Herbs. Boca Raton, FL: CRC Press.
28. Hwang, J. T., S. H. Kim, M. S. Lee et al. 2007. Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyte. Biochem Biophys Res Commun 364:1002-8.
29. Hwang, J. T., M. S. Lee, H. J. Kim et al. 2009. Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR-γ signal pathways. Phytother Res 23:262-6.
30. Hwang, J. T., J. I. Park, Y. K. Shin et al. 2005. Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 338:694-9.
31. Jia, W. W., X. Bu, D. Philips et al. 2004. Rh2, a compound extracted from ginseng, hypersensitizes multidrugresistance tumor cells to chemotherapy. Can J Physiol Pharmacol 82:431-7.
32. Jin, J., S. Shahi, H. K. Kang, H. W. van Veen, and T. P. Fan. 2006. Metabolite of ginsenosides as novel BCRP inhibitors. Biochem Biophys Res Commun 345:1308-14.
33. Joo, S. S., Y. M. Yoo, B. W. Ahn et al. 2008. Prevention of inflammation-mediated neurotoxicity by Rg3 and its role in microglial activation. Biol Pharm Bull 31:1392-6.
34. Jung, N. P., and S. H. Jin. 1996. Studies on the physiological and biochemical effect of Korean ginseng. Korean J Ginseng Sci 20:431-71.
35. Jung, S. H., M. S. Woo, S. Y. Kim et al. 2006. Ginseng saponin metabolite suppresses phorbol ester-induced matrix metallpproteinase-9 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathway in human astroglioma cells. Int J Cancer 118:490-7.
36. Kamangar, F., Y. T. Gao, X. O. Shu et al. 2007. Ginseng intake and gastric cancer risk in the Shanghai women's health study cohort. Cancer Epidemiol Biomarkers Prev 16:629-630.
37. Kasai, R., H. Besso, O. Tanaka, Y. I. Saruwatari, and T. Mizutare. 1983. Saponins of red ginseng. Chem Pharm Bull 31:2120-5.
38. Kim, J. H., S. Y. Cho, J. H. Lee et al. 2007. Neuroprotective effects of ginsenoside Rg3 against homocysteineinduced excitotoxicity in rat hippocampus. Brain Res 1136:190-9.
39. Kim, K., and H. Y. Kim. 2008. Korean red ginseng stimulates insulin release from isolated rat pancreatic islets. J Ethnopharmacol 120:190-5.
40. Kim, S., T. Kim, K. Ahn, W. K. Park, S. Y. Nah, and H. Rhim. 2004. Ginsenoside Rg3 antagonizes NMDA receptors through a glycine modulatory site in rat cultured hippocampal neurons. Biochem Biophys Res Commun 323:416-24.
41. Kim, H. J., M. H. Kim, Y. Y. Byon, J. W. Park, Y. Jee, and H. G. Joo. 2007. Radioprotective effects of an acidic polysaccharide of Panax ginseng on bone marrow cells. J Vet Sci 8:39-44.
42. Kim, W. Y., J. M. Kim, S. B. Han et al. 2000. Steaming of ginseng at high temperature enhances biological activity. J Nat Prod 63:1702-4.
43. Kim, S. W., H. Y. Kwon, D. W. Chi et al. 2003. Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg(3). Biochem Pharmacol 65:58-61.
44. Kim, H. S., E. H. Lee, S. R. Ko, K. J. Choi, J. H. Park, and D. S. Im. 2004. Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Arch Pharm Res 27:429-35.
45. Kimura, M., I. Waki, T. Chujo et al. 1981. Effects of hypoglycemic components in ginseng radix on blood insulin level in alloxan diabetic mice and on insulin release from perfused rat pancreas. J Pharmacobiodyn 4:410-7.
46. Kitagawa, I., M. Yoshikawa, M. Yoshihara, T. Hayashi, and T. Taniyama. 1983. Chemical studies on crude drug processing I. On the constituents of Ginseng Radix Rubra. Yakugaku Zasshi 103:612-22.
47. Kumar, A. 1993. Chemopreventive action of ginseng on DMBA-induced papillomagenesis in the skin of mice. Proceedings of the 6th International Ginseng Symposium, (Seoul, Korea), 66-8.
48. Kwon, H. Y., E. H. Kim, S. W. Kim, S. N. Kim, J. D. Park, and D. K. Rhee. 2008. Selective toxicity of ginsenoside Rg3 on multidrug resistance cells by membrane fluidity modulation. Arch Pharm Res 31:171-7.
49. Lee, F. C. 1992. About Ginseng: The Elixir of Life. Elizabeth, NJ: Hollin International Corp.
50. Lee, J. H., and Y. Han. 2006. Ginsenoside Rg1 helps mice resist to disseminated candidiasis by Th1 type differentiation of CD4+ T cell. Int Immunopharmacol 6:1424-30.
51. Lee, W. K., S. T. Kao, I. M. Liu, and J. T. Cheng. 2006. Increase of insulin secretion by ginsenoside Rh2 to lower plasma glucose in Wistar rats. Clin Exp Pharmcol Physiol 33:27-32.
52. Lee, E., S. Kim, K. C. Chun et al. 2006. 20(S)-ginsenoside Rh2, a newly identified active ingredient of ginseng, inhibits NMDA receptors in cultured rat hippocampal neurons. Eur J Pharmacol 536:69-77.
53. Lee, E. J., E. Ko, J. Lee et al. 2004. Ginsenoside Rg1 enhances CD4(+) T-cell activities and modulates Th1/Th2 differentiation. Int Immunopharmacol 4:235-44.
54. Lee, J. Y., J. W. Shin, K. S. Chun et al. 2005. Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin. Carcinogenesis 26:359-67.
55. Lee, J. M., G. J. Zipfel, and D. W. Choi. 1999. The changing landscape of ischaemic brain injury mechanisms. Nature 399:A7-14.
56. Lehrke, M., and M. A. Lazar. 2005. The many faces of PPARgamma. Cell 123:993-9.
57. Leung, K. W., L. W. T. Cheung, Y. L. Pon et al. 2007. Ginsenoside Rb1 inhibits tube-like structure formation of endothelial cells by regulating pigment epithelium-derived factor through the oestrogen β receptor. British J Pharm 152:207-15.
58. Li, J. Q., Z. K. Li, H. Duan, and J. T. Zhang. 1997. Effect of age and ginsenoside Rg1 on nitric oxide content and nitric oxide synthase activity of cerebral cortex on rats. Acta Pharm Sin 32:251-4.
59. Li, X. L., C. Z. Wang, S. R. Mehendale, S. Sun, Q. Wang, and C. S. Yuan. 2009. Panaxadiol, a purified ginseng component, enhances the anti-cancer effects of 5-fluorouracil in human colorectal cancer cells. Cancer Chemother Pharmacol 64(6):1097-104.
60. Li, G., Z. Wang, Y. Sun, K. Liu, and Z. Wang. 2006. Ginsenoside 20(S)-protopanaxadiol inhibits the proliferation and invasion of human fibrosarcoma HT1080 cells. Basic Clin Pharmacol Toxicol 98:588-92.
61. Li, J., G. Zhang, and J. T. Zhang. 1997. Inhibition of apoptosis by ginsenoside Rg1 in cultured cortical neurons. Acta Pharm Sin 32:406-10.
62. Liao, B. C., R. C. Hou, J. S. Wang, and K. C. Jeng. 2006. Enhancement of the release of inflammatory mediators by substance P in rat basophilic leukemia RBL-2H3 cells. J Biomed Sci 13:613-9.
63. Liou, C. J., W. C. Huang, and J. Tseng. 2005. Long-term oral administration of ginseng extract modulates humoral immune response and spleen cell functions. Am J Chin Med 33:651-61.
64. Liu, T. P., I. M. Liu, and J. T. Cheng. 2005. Improvement of insulin resistance by Panax ginseng in fructose-rich chow-fed rats. Horm Metab Res 37:333-9.
65. Luo, J. Z., and L. Luo. 2008. Ginseng on hyperglycemia: Effects and mechanisms. eCAM 6:423-7.
66. Luo, J. Z., N. Yano, and L. Luo. 2003. American ginseng stimulates insulin production and prevents apoptosis induced by IL-1β in pancreatic β cells. Diabetes 52(Suppl. 1):A354-1534-P.
67. Mochizuki, M., Y. C. Yoo, and K. Matsuzawa. 1995. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng. Biol Pharm Bull 18:1197-202.
68. Molnar, J., D. Szabo, R. Pusztal et al. 2000. Membrane associated antitumor effects of crocine-, ginsenosideand cannabinoid derivatives. Anticancer Res 20:861-7.
69. Nedergaard, J., N. Petrovic, E. M. Lindgren et al. 2005. PPARgamma in the control of brown adipocyte differentiation. Biochem Biophys Acta 1740:293-304.
70. Panwar, M., R. Samarth, M. Kumar, W. J. Yoon, and A. Kumar. 2005. Inhibition of benzo(a)pyrene induced lung adenoma by Panax ginseng extract, EFLA400, in Swiss albino mice. Biol Pharm Bull 28:2063-7.
71. Park, S., I. S. Ahn, D. Y. Kwon, B. S. Ko, and W. K. Jun. 2008. Ginsenoside Rb1 and Rg1 suppress triglyceride accumulation in 3T3-L1 adipocytes and enhance β-cell insulin secretion and viability in Min6 cells via PKA-dependent pathways. Biosci Biotechnol Biochem 72:2815-23.
72. Park, E. K., M. K. Choo, J. K. Oh, J. H. Ryu, and D. H. Kim. 2004. Ginsenoside Rh2 reduces ischemic brain injury in rat. Biol Pharm Bull 27:433-6.
73. Park, M. W., J. Ha, and S. H. Chung. 2008. 20(S)-ginsenoside Rg3 enhances glucose-stimulated insulin secretion and activates AMPK. Biol Pharm Bull 31(4):748-51.
74. Park, J. D., D. S. Kim, S. K. Son et al. 1996. Effect of ginseng saponin on modulation of multidrug resistance. Arch Pharm Res 19:213-8.
75. Park, S. E., C. Park, S. H. Kim et al. 2009. Korean red ginseng extract induces apoptosis and decreases telomerase activity in human leukemia cells. J Ethnopharmacol 121:304-12.
76. Park, T. Y., M. H. Park, W. C. Shin et al. 2008. Anti-metastatic potential of ginsenoside Rp1, a novel ginsenoside derivative. Biol Pharm Bull 31:1802-5.
77. Park, J. D., D. K. Rhee, and Y. H. Lee. 2005. Biological activities and chemistry of saponins from Panax ginsengC. A. Meyer. Phytochem Rev 4:159-75.
78. Park, K. H., H. J. Shin, Y. B. Song et al. 2002. Possible role of ginsenoside Rb1 on regulation of rat liver triglycerides. Biol Pharm Bull 25:457-60.
79. Qiu, Y., G. H. Du, Z. W. Qu, and J. T. Zhang. 1995. Protective effects of ginsenoside on the learning and memory impairment induced by transient cerebral ischemia-reperfusion in mice. Chin Pharmacol Bull 11:299-302.
80. Quan, F. S., R. W. Compans, Y. K. Cho, and S. M. Kang. 2007. Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection. Vaccine 25:272-82.
81. Shang, W., Y. Yang, L. Zhou et al. 2008. Ginsenoside Rb1 stimulates glucose uptake through insulin-like signaling pathway in 3T3-L1 adipocytes. J Endocrinol 198:561-9.
82. Shibata, S., O. Tanaka, J. Shoji, and H. Saito. 1995. Chemistry and pharmacology of Panax ginseng. In Economic and Medicinal Plant Research, ed. H. Wagner, H. Kikino, and N. R. Farnsworth, vol. 1, 217-84. New York: Academic Press.
83. Shieh, P. C., C. W. Tsao, J. S. Li et al. 2008. Role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the action of ginsenoside Rh2 against beta-amyloid-induced inhibition of rat brain astrocytes. Neurosci Lett 434:1-5.
84. Song, Z., C. Moser, H. Wu, V. Faber, A. Kharazmi, and N. HØiby. 2003. Cytokine modulating effect of ginseng treatment in a mouse model of Pseudomonas aeruginosa lung infection. J Cyst Fibros 2:112-9.
85. Song, X., L. Zang, and S. Hu. 2009. Amplified immune response by ginsenoside-based nanoparticles (ginsomes). Vaccine 27:2306-11.
86. Sotaniemi, E. A., E. Haapakoski, and A. Rautio. 1995. Ginseng therapy in non-insulin dependent diabetic patients. Diabetes Care 18:1373-5.
87. Su, C. F., J. T. Cheng, and I. M. Li. 2007. Increase of acetylcholine release by Panax ginseng root enhances insulin secretion in Wistar rats. Neurosci Lett 412:101-4.
88. Sun, J., S. Hu, and X. Song. 2007. Adjuvant effects of protopanaxadiol and protopanaxatriol saponins from ginseng roots on the immune responses to ovalbumin in mice. Vaccine 25:1114-20.
89. Surh, Y. J., J. Y. Lee, K. J. Choi, and S. R. Ko. 2002. Effects of selected ginsenosides on phorbol ester-induced expression of cyclooxygenase-2 and activation of NF-κB and ERK1/2 in mouse skin. Ann N Y Acad Sci 973:396-401.
90. Takagi, K., H. Saito, and H. Nabata. 1972. Pharmacological studies of Panax ginseng root: Estimation of pharmacological actions of Panax ginseng root. Jpn J Pharmacol 22:245-9.
91. Takei, M., E. Tachikawa, H. Hasegawa, and J. J. Lee. 2004. Dendritic cells maturation promoted by M1 and M4, end products of steroidal ginseng saponins metabolized in digestive tracts, drive a potent Th1 polarization. Biochem Pharmacol 68:441-52.
92. 2+and glutamate release. J Neurochem 53:1693-9.
93. Tomoda, M., K. Hirabayashi, N. Shimizu, R. Gonda, N. Ohara, and K. Takada. 1993. Characterization of two novel polysaccharides having immunological activities from the root of Panax ginseng. Biol Pharm Bull 16(11):1087-90.
94. Vulksan, V., J. L. Sievenpiper, V. Y. Koo et al. 2000. American ginseng (Panax quinquefolius L.) reduces postprandial glycemia in nondiabetic subjects with type 2 diabetes mellitus. Arch Intern Med 160:1009-13.
95. Vulksan, V., J. Sievenpiper, J. Wong et al. 2001. American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals. Am J Clin Nutr 73:753-8.
96. Vulksan, V., M. K. Sung, J. L. Sievenpiper et al. 2008. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled study of efficacy and safety. Nutr Metab Cardiovasc Dis 18:46-56.
97. Wang, C. Z., and C. S. Yuan. Potential role of ginseng in the treatment of colorectal cancer. Am J Chin Med 36:1019-28.
98. Wang, X. Y., and J. T. Zhang. 2001. Effects of ginsenoside Rg1 on learning and memory impairment induced by β-amyloid peptide (25-35) and its mechanism of action. Acta Pharm Sin 36:1-4.
99. Weinstein, I. B. 1991. Cancer prevention: Recent progress and future opportunities. Cancer Res 51(18 Suppl.):5080s-5s.
100. Wu, X. G., D. H. Zhu, and W. Li. 2001. Anticarcinogenic effect of red ginseng on the development of liver cancer induced by diethylnitrosamine in rats. J Korean Med Sci 16(Suppl.):S61-5.
101. Xie, J. T., S. Mehendale, and C. S. Yuan. 2005. Ginseng and diabetes. Am J Chin Med 33:397-404.
102. Xu, T. M., M. H. Cui, M. Jiang et al. 2008. Inhibitory effect of ginsenoside Rg3 on ovarian cancer. Chin Med J 121:1394-7.
103. Xu, T. M., Y. Xin, M. H. Cui, X. Jiang, and L. Gu. 2007. Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer. Chin Med J 120:584-8.
104. Yang, L., J. Hao, J. Zhang et al. 2009. Ginsenoside Rg3 promotes beta-amyloid peptide degradation by enhancing gene expression of neprilysin. J Pharm Pharmacol 61:375-80.
105. Yang, C. S., S. R. Ko, B. G. Cho et al. 2008. The ginsenoside metabolite compound K, a novel agonist of glucocorticoid receptor induces tolerance to endotoxin-induced lethal shock. J Cell Mol Med 12:1739-53.
106. Yin, W., J. Mu, and M. J. Birnbaum. 2003. Role of AMP-activated protein kinase in cyclin AMP-dependent lipolysis in 3T3-L1 adipocytes. J Biol Chem 278:43074-80.
107. Yoshikawa, M., T. Murakami, K. Yashiro et al. 1998. Bioactive saponins and glycosides, XI. Structure of new dammarane-type triterpene oligoglycosides, quinquenosides II, I, IV, III, and V, from American ginseng, the roots of Panax quinquefolium L. Chem Pharm Bull (Tokyo) 46:647-54.
108. Yun, T. K. 2003. Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds. Mutat Res 523-524:63-74.
109. Yun, T. K., Y. S. Lee, Y. H. Lee, S. I. Kim, and H. Y. Yun. 2001. Anticarcinogenic effect of Panax ginseng C.A. Meyer and identification of active compounds. J Korean Med Sci 16 (Suppl.):S6-18.
110. Yun, S. N., S. J. Moon, S. K. Ko et al. 2004. Wild ginseng prevents the onset of high-fat diet induced hyper glycemia and obesity in ICR mice. Arch Pharm Res 27:790-6.
111. Yun, T. K., Y. S. Yun, and I. W. Han. 1983. Anticarcinogenic effect of long-term oral administration of red ginseng on new mice exposed to various chemical carcinogens. Cancer Detect Prev 6:515-25.
112. Zeng, X. I., and Z. G. Tu. 2003. In vitro induction of differentiation by ginsenoside Rh2 in SMMC-7721 hepatocarcinoma cell line. Pharmcol Toxicol 93:275-83.
113. Zhang, Q., X. Kang, and W. Zhao. 2006. Antiangiogenic effect of low-dose cyclophosphamide combined with ginsenoside Rg3 on Lewis lung carcinoma. Biochem Biophys Res Commun 342:824-8.
114. Zhang, F., B. Lavan, and F. M. Greggore. 2004. Peroxisome proliferator-activated receptors as attractive antiobesity targets. Drug News Prespect 17:661-9.
115. Zhang, J. T., Y. Liu, Z. W. Qu, X. L. Zhang, and H. L. Xiao. 1988. Influence of ginsenoside Rb1 and Rg1 on some central neurotransmitter receptors and protein biosynthesis in mouse brain. Acta Pharm Sin 23:12-16.
116. Zhang, H., Z. Lu, G. T. Tan et al. 2002. Polyacetyleneginsenoside-Ro, a novel triterpene saponin from Panax ginseng. Tetrahedron Lett 43:973-7.
117. Zhang, J. T., Z. W. Qu, Y. Liu, and H. L. Deng. 1990. Preliminary study on antiamnestic mechanism of ginsenoside Rg1 and Rb1. Chin Med J 103:932-8.